Use of adjuvant pharmacotherapy in type 1 diabetes: International comparison of 49,996 individuals in the prospective diabetes follow-up and T1D exchange registries

Sarah K. Lyons, Julia M. Hermann, Kellee M. Miller, Sabine E. Hofer, Nicole C. Foster, Birgit M. Rami-Merhar, Grazia Aleppo, Jochen Seufert, Linda A. DiMeglio, Thomas Danne, David M. Maahs, Reinhard W. Holl

Research output: Contribution to journalLetter

23 Scopus citations
Original languageEnglish (US)
Pages (from-to)e139-e140
JournalDiabetes care
Volume40
Issue number10
DOIs
StatePublished - Oct 1 2017

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this

Lyons, S. K., Hermann, J. M., Miller, K. M., Hofer, S. E., Foster, N. C., Rami-Merhar, B. M., Aleppo, G., Seufert, J., DiMeglio, L. A., Danne, T., Maahs, D. M., & Holl, R. W. (2017). Use of adjuvant pharmacotherapy in type 1 diabetes: International comparison of 49,996 individuals in the prospective diabetes follow-up and T1D exchange registries. Diabetes care, 40(10), e139-e140. https://doi.org/10.2337/dc17-0403